CalciMedica Statistics Share Statistics CalciMedica has 13.97M
shares outstanding. The number of shares has increased by 29.97%
in one year.
Shares Outstanding 13.97M Shares Change (YoY) 29.97% Shares Change (QoQ) 3.64% Owned by Institutions (%) 0.03% Shares Floating 5.99M Failed to Deliver (FTD) Shares 91 FTD / Avg. Volume 0.12%
Short Selling Information The latest short interest is 35.59K, so 0.25% of the outstanding
shares have been sold short.
Short Interest 35.59K Short % of Shares Out 0.25% Short % of Float 0.38% Short Ratio (days to cover) 1.01
Valuation Ratios The PE ratio is -2.91 and the forward
PE ratio is -2.27.
CalciMedica's PEG ratio is
0.03.
PE Ratio -2.91 Forward PE -2.27 PS Ratio 0 Forward PS 20 PB Ratio 2.76 P/FCF Ratio -1.88 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CalciMedica.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.34,
with a Debt / Equity ratio of 0.
Current Ratio 5.34 Quick Ratio 5.34 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-978.57K Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -20.86% in the
last 52 weeks. The beta is 1.27, so CalciMedica's
price volatility has been higher than the market average.
Beta 1.27 52-Week Price Change -20.86% 50-Day Moving Average 2.81 200-Day Moving Average 2.41 Relative Strength Index (RSI) 63.83 Average Volume (20 Days) 75,664
Income Statement
Revenue n/a Gross Profit -58K Operating Income -24.2M Net Income -13.7M EBITDA -13.64M EBIT -13.7M Earnings Per Share (EPS) -1.22
Full Income Statement Balance Sheet The company has 7.93M in cash and 0 in
debt, giving a net cash position of 7.93M.
Cash & Cash Equivalents 7.93M Total Debt n/a Net Cash n/a Retained Earnings -159.76M Total Assets 19.08M Working Capital 15.49M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -21.15M
and capital expenditures -8K, giving a free cash flow of -21.15M.
Operating Cash Flow -21.15M Capital Expenditures -8K Free Cash Flow -21.15M FCF Per Share -1.88
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields CALC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CALC is $14.5,
which is 315.5% higher than the current price. The consensus rating is "Buy".
Price Target $14.5 Price Target Difference 315.5% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 20, 2023. It was a
backward
split with a ratio of 1:14.
Last Split Date Mar 20, 2023 Split Type backward Split Ratio 1:14
Scores Altman Z-Score -13.56 Piotroski F-Score 2
